Literature DB >> 22037550

Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1.

Anthony J Valente1, Tadashi Yoshida2, Jason D Gardner3, Naveen Somanna4, Patrice Delafontaine5, Bysani Chandrasekar6.   

Abstract

The dual-specificity mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) inactivates MAP kinases by dephosphorylation. Here we show that the proinflammatory cytokine interleukin (IL)-17A induces adult mouse primary cardiac fibroblast (CF) proliferation and migration via IL-17 receptor A//IL-17 receptor C-dependent MKP-1 suppression, and activation of p38 MAPK and ERK1/2. IL-17A mediated p38 MAPK and ERK1/2 activation is inhibited by MKP-1 overexpression, but prolonged by MKP-1 knockdown. IL-17A induced miR-101 expression via PI3K/Akt, and miR-101 inhibitor reversed MKP-1 down regulation. Importantly, MKP-1 knockdown, pharmacological inhibition of p38 MAPK and ERK1/2, or overexpression of dominant negative MEK1, each markedly attenuated IL-17A-mediated CF proliferation and migration. Similarly, IL-17F and IL-17A/F heterodimer that also signal via IL-17RA/IL-17RC, stimulated CF proliferation and migration. These results indicate that IL-17A stimulates CF proliferation and migration via Akt/miR-101/MKP-1-dependent p38 MAPK and ERK1/2 activation. These studies support a potential role for IL-17 in cardiac fibrosis and adverse myocardial remodeling.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037550      PMCID: PMC3339406          DOI: 10.1016/j.cellsig.2011.10.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  24 in total

1.  Cardiac fibroblasts influence cardiomyocyte phenotype in vitro.

Authors:  W A LaFramboise; D Scalise; P Stoodley; S R Graner; R D Guthrie; J A Magovern; M J Becich
Journal:  Am J Physiol Cell Physiol       Date:  2007-01-17       Impact factor: 4.249

Review 2.  The JNK signal transduction pathway.

Authors:  Claire R Weston; Roger J Davis
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

3.  Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.

Authors:  C C Franklin; A S Kraft
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

Review 4.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

Review 5.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

6.  The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade.

Authors:  J M Brondello; A Brunet; J Pouysségur; F R McKenzie
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

7.  IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms.

Authors:  Søren Ulrik Sønder; Sun Saret; Wanhu Tang; Dan E Sturdevant; Stephen F Porcella; Ulrich Siebenlist
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

Review 8.  Dual-specificity phosphatase 1: a critical regulator of innate immune responses.

Authors:  S M Abraham; A R Clark
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

9.  Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation.

Authors:  Devang N Patel; Carter A King; Steven R Bailey; Jeffrey W Holt; Kaliyamurthi Venkatachalam; Alok Agrawal; Anthony J Valente; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2007-07-25       Impact factor: 5.157

Review 10.  Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

Authors:  S M Keyse
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

View more
  42 in total

1.  Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death.

Authors:  Tadashi Yoshida; Nitin A Das; Andrea J Carpenter; Reza Izadpanah; Senthil A Kumar; Sandeep Gautam; Shawn B Bender; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

2.  Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.

Authors:  M Sisto; L Lorusso; R Tamma; G Ingravallo; D Ribatti; S Lisi
Journal:  Clin Exp Immunol       Date:  2019-06-05       Impact factor: 4.330

Review 3.  Targeted therapies for systemic sclerosis.

Authors:  Christopher P Denton; Voon H Ong
Journal:  Nat Rev Rheumatol       Date:  2013-04-09       Impact factor: 20.543

Review 4.  Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis.

Authors:  Shuvra Ray; Carlo De Salvo; Theresa T Pizarro
Journal:  Curr Opin Gastroenterol       Date:  2014-11       Impact factor: 3.287

5.  T3 peptide, a fragment of tumstatin, stimulates proliferation and migration of cardiac fibroblasts through activation of Akt signaling pathway.

Authors:  Jumpei Yasuda; Kana Fukui; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-07       Impact factor: 3.000

6.  Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Siva S V P Sakamuri; Tadashi Yoshida; Jason D Gardner; Naveen Somanna; Chiaki Takahashi; Makoto Noda; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2013-10-02       Impact factor: 5.000

Review 7.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).

Authors:  Ruijie Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2016-08-27       Impact factor: 5.000

8.  Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.

Authors:  Manjunath Yariswamy; Tadashi Yoshida; Anthony J Valente; Hemanth Kumar Kandikattu; Siva S V P Sakamuri; Jalahalli M Siddesha; Sergiy Sukhanov; Zubaida Saifudeen; Lixin Ma; Ulrich Siebenlist; Jason D Gardner; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

9.  Immune activation caused by vascular oxidation promotes fibrosis and hypertension.

Authors:  Jing Wu; Mohamed A Saleh; Annet Kirabo; Hana A Itani; Kim Ramil C Montaniel; Liang Xiao; Wei Chen; Raymond L Mernaugh; Hua Cai; Kenneth E Bernstein; Jörg J Goronzy; Cornelia M Weyand; John A Curci; Natalia R Barbaro; Heitor Moreno; Sean S Davies; L Jackson Roberts; Meena S Madhur; David G Harrison
Journal:  J Clin Invest       Date:  2015-11-23       Impact factor: 14.808

10.  TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiation.

Authors:  Anthony J Valente; Siva S V P Sakamuri; Jalahalli M Siddesha; Tadashi Yoshida; Jason D Gardner; Ramesh Prabhu; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2013-07-18       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.